Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

10 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
T2-weighted, apparent diffusion coefficient and 18F-FDG PET histogram analysis of rectal cancer after preoperative chemoradiotherapy.
Crimì F, Stramare R, Spolverato G, Aldegheri V, Barison A, D'Alimonte L, Bao QR, Spimpolo A, Albertoni L, Cecchin D, Campi C, Quaia E, Pucciarelli S, Zucchetta P. Crimì F, et al. Among authors: spimpolo a. Tech Coloproctol. 2021 May;25(5):569-577. doi: 10.1007/s10151-021-02440-9. Epub 2021 Apr 1. Tech Coloproctol. 2021. PMID: 33792823 Free PMC article.
[18F]FDG PET/MRI in rectal cancer.
Crimì F, Valeggia S, Baffoni L, Stramare R, Lacognata C, Spolverato G, Albertoni L, Spimpolo A, Evangelista L, Zucchetta P, Cecchin D, Pucciarelli S. Crimì F, et al. Among authors: spimpolo a. Ann Nucl Med. 2021 Mar;35(3):281-290. doi: 10.1007/s12149-021-01580-0. Epub 2021 Jan 31. Ann Nucl Med. 2021. PMID: 33517562 Free PMC article. Review.
Volumetric histograms-based analysis of apparent diffusion coefficients and standard uptake values for the assessment of pediatric sarcoma at staging: preliminary results of a PET/MRI study.
Orsatti G, Zucchetta P, Varotto A, Crimì F, Weber M, Cecchin D, Bisogno G, Spimpolo A, Giraudo C, Stramare R. Orsatti G, et al. Among authors: spimpolo a. Radiol Med. 2021 Jun;126(6):878-885. doi: 10.1007/s11547-021-01340-0. Epub 2021 Mar 8. Radiol Med. 2021. PMID: 33683542
PET/MR in recurrent glioblastoma patients treated with regorafenib: [18F]FET and DWI-ADC for response assessment and survival prediction.
Lombardi G, Spimpolo A, Berti S, Campi C, Anglani MG, Simeone R, Evangelista L, Causin F, Zorzi G, Gorgoni G, Caccese M, Padovan M, Zagonel V, Cecchin D. Lombardi G, et al. Among authors: spimpolo a. Br J Radiol. 2022 Jan 1;95(1129):20211018. doi: 10.1259/bjr.20211018. Epub 2021 Nov 23. Br J Radiol. 2022. PMID: 34762492 Free PMC article.
Can Baseline [18F]FDG PET/CT Predict Response to Immunotherapy After 6 Months and Overall Survival in Patients with Lung Cancer or Malignant Melanoma? A Multicenter Retrospective Study.
Bianchi A, De Rimini ML, Sciuto R, Annovazzi A, Di Traglia S, Bauckneht M, Lanfranchi F, Morbelli S, Nappi AG, Ferrari C, Rubini G, Panareo S, Urso L, Bartolomei M, D'Arienzo D, Valente T, Rossetti V, Caroli P, Matteucci F, Aricò D, Bombaci M, Caponnetto D, Bertagna F, Albano D, Dondi F, Gusella S, Spimpolo A, Carriere C, Balma M, Buschiazzo A, Gallicchio R, Storto G, Ruffini L, Scarlattei M, Baldari G, Cervino AR, Cuppari L, Burei M, Trifirò G, Brugola E, Zanini CA, Alessi A, Fuoco V, Seregni E, Deandreis D, Liberini V, Moreci AM, Ialuna S, Pulizzi S, Evangelista L. Bianchi A, et al. Among authors: spimpolo a. Cancer Biother Radiopharm. 2023 May;38(4):256-267. doi: 10.1089/cbr.2022.0092. Epub 2023 Apr 25. Cancer Biother Radiopharm. 2023. PMID: 37098169
ITA-IMMUNO-PET: The Role of [18F]FDG PET/CT for Assessing Response to Immunotherapy in Patients with Some Solid Tumors.
Evangelista L, Bianchi A, Annovazzi A, Sciuto R, Di Traglia S, Bauckneht M, Lanfranchi F, Morbelli S, Nappi AG, Ferrari C, Rubini G, Panareo S, Urso L, Bartolomei M, D'Arienzo D, Valente T, Rossetti V, Caroli P, Matteucci F, Aricò D, Bombaci M, Caponnetto D, Bertagna F, Albano D, Dondi F, Gusella S, Spimpolo A, Carriere C, Balma M, Buschiazzo A, Gallicchio R, Storto G, Ruffini L, Cervati V, Ledda RE, Cervino AR, Cuppari L, Burei M, Trifirò G, Brugola E, Zanini CA, Alessi A, Fuoco V, Seregni E, Deandreis D, Liberini V, Moreci AM, Ialuna S, Pulizzi S, De Rimini ML. Evangelista L, et al. Among authors: spimpolo a. Cancers (Basel). 2023 Jan 31;15(3):878. doi: 10.3390/cancers15030878. Cancers (Basel). 2023. PMID: 36765835 Free PMC article.